1. Home
  2. RLAY vs APAM Comparison

RLAY vs APAM Comparison

Compare RLAY & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$13.50

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

HOLD

Current Price

$37.56

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
APAM
Founded
2015
1994
Country
United States
United States
Employees
N/A
567
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
RLAY
APAM
Price
$13.50
$37.56
Analyst Decision
Strong Buy
Hold
Analyst Count
10
5
Target Price
$19.50
$43.00
AVG Volume (30 Days)
3.8M
625.6K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
10.81%
EPS Growth
31.78
10.66
EPS
N/A
0.76
Revenue
$15,355,000.00
$1,196,688,000.00
Revenue This Year
N/A
$5.96
Revenue Next Year
$324.03
$5.05
P/E Ratio
N/A
$48.75
Revenue Growth
53.44
7.63
52 Week Low
$2.83
$34.99
52 Week High
$17.32
$48.46

Technical Indicators

Market Signals
Indicator
RLAY
APAM
Relative Strength Index (RSI) 54.25 53.07
Support Level $11.75 $35.29
Resistance Level $17.32 $38.49
Average True Range (ATR) 0.94 0.78
MACD 0.01 -0.01
Stochastic Oscillator 49.61 72.87

Price Performance

Historical Comparison
RLAY
APAM

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

Share on Social Networks: